[144] Arcosa, Inc. SEC Filing

Rhea-AI Filing Summary

Arcosa, Inc. (ACA) submitted a Form 144 reporting a proposed sale of 7,966 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $762,903.82 and an approximate sale date of 08/11/2025. The filing shows these shares were acquired as restricted stock from the issuer on 05/15/2024 and that payment was not applicable at acquisition.

The filer indicates nothing to report for securities sold in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer. Several filer identification fields are blank or not shown in the visible content.

Insights

Securities Analyst

TL;DR: Routine insider notice: small proposed sale of 7,966 shares (aggregate value $762,903.82) planned via Morgan Stanley on NYSE.

The Form 144 discloses a proposed disposition of 7,966 common shares with an aggregate market value of $762,903.82, scheduled approximately for 08/11/2025. The securities were acquired as restricted stock from the issuer on 05/15/2024. The filing reports no sales in the past three months and includes the customary certification about material nonpublic information. Based on the disclosed counts, this appears procedural and lacks other material disclosures.

Corporate Governance Expert

TL;DR: Governance disclosure appears standard: restricted stock converted to sale notice, with broker and exchange specified.

The notice names Morgan Stanley Smith Barney LLC as broker and specifies the NYSE as the exchange. It documents acquisition from the issuer as restricted stock on 05/15/2024 and an intended sale date of 08/11/2025. The filing includes the required attestation regarding undisclosed material adverse information. No governance-related red flags or additional context are provided in the visible content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7966	762903.82	49044906	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2024	Restricted Stock	Issuer			7966	05/15/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Arcosa's (ACA) Form 144 disclose?

The filing discloses a proposed sale of 7,966 common shares valued at $762,903.82, to be executed via Morgan Stanley Smith Barney LLC on the NYSE with an approximate sale date of 08/11/2025.

When and how were the securities being sold on ACA acquired?

The securities were acquired as restricted stock from the issuer on 05/15/2024, with 7,966 shares listed for sale and payment marked Not Applicable at acquisition.

Did the filer report any ACA sales in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Who is the broker handling the proposed ACA sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the Form 144 include any statements about material nonpublic information?

Yes. The filer signs the notice representing they do not know any material adverse information about the issuer that has not been publicly disclosed.